Cereno Scientific Balance Sheet Health
Financial Health criteria checks 3/6
Cereno Scientific has a total shareholder equity of SEK253.5M and total debt of SEK45.4M, which brings its debt-to-equity ratio to 17.9%. Its total assets and total liabilities are SEK332.8M and SEK79.3M respectively.
Key information
17.9%
Debt to equity ratio
SEK 45.40m
Debt
| Interest coverage ratio | n/a |
| Cash | SEK 85.60m |
| Equity | SEK 253.49m |
| Total liabilities | SEK 79.29m |
| Total assets | SEK 332.78m |
Financial Position Analysis
Short Term Liabilities: CRNO B's short term assets (SEK90.1M) exceed its short term liabilities (SEK33.9M).
Long Term Liabilities: CRNO B's short term assets (SEK90.1M) exceed its long term liabilities (SEK45.4M).
Debt to Equity History and Analysis
Debt Level: CRNO B has more cash than its total debt.
Reducing Debt: CRNO B's debt to equity ratio has increased from 0.6% to 17.9% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: CRNO B has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: CRNO B has less than a year of cash runway if free cash flow continues to reduce at historical rates of 37.8% each year